成大生物
(688739)
| 流通市值：54.39亿 | | | 总市值：119.98亿 |
| 流通股本：1.89亿 | | | 总股本：4.16亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 364,709,258.37 | 1,750,103,088.24 | 1,334,694,071.78 | 871,308,922.37 |
| 营业收入 | 364,709,258.37 | 1,750,103,088.24 | 1,334,694,071.78 | 871,308,922.37 |
| 二、营业总成本 | 257,814,176.43 | 1,103,923,313.7 | 764,513,158.97 | 474,257,967.35 |
| 营业成本 | 62,377,750.72 | 286,150,196.66 | 196,528,634.32 | 129,890,811.56 |
| 税金及附加 | 5,320,831.72 | 21,859,833.51 | 16,447,129.17 | 10,615,533.85 |
| 销售费用 | 86,103,841.5 | 397,514,521.13 | 293,892,286.59 | 173,741,583.34 |
| 管理费用 | 59,663,725.44 | 250,278,441.47 | 176,169,771.62 | 109,763,326.79 |
| 研发费用 | 58,997,464.13 | 220,464,212.85 | 139,290,606.86 | 90,908,954.12 |
| 财务费用 | -14,649,437.08 | -72,343,891.92 | -57,815,269.59 | -40,662,242.31 |
| 其中:利息费用 | 225,274.41 | 1,418,072.57 | 750,794.4 | 509,822.43 |
| 其中:利息收入 | 14,967,931 | 71,787,417.75 | 57,072,634.34 | 39,594,369.47 |
| 加:公允价值变动收益 | 4,547,164.17 | 8,102,948.8 | 5,373,742.01 | 5,231,449.39 |
| 加:投资收益 | 2,821,281.49 | 25,022,730.62 | 22,391,909.76 | 13,009,174.06 |
| 资产处置收益 | 43,073.13 | 2,482,317.43 | 33,624.83 | 8,811.65 |
| 资产减值损失(新) | -10,711,140.75 | -109,805,229.7 | -45,159,991.88 | -13,943,068.39 |
| 信用减值损失(新) | -1,457,802.36 | -13,088,976.99 | -14,181,866.08 | -10,470,420.6 |
| 其他收益 | 5,884,211.9 | 18,901,991.16 | 14,575,643.92 | 10,031,379.91 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 108,021,869.52 | 577,795,555.86 | 553,213,975.37 | 400,918,281.04 |
| 加:营业外收入 | 1,000 | 1,539,545.6 | 54,000 | 50,000 |
| 减:营业外支出 | 55,822.19 | 2,955,337.88 | 1,213,887.59 | 477,970.25 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 107,967,047.33 | 576,379,763.58 | 552,054,087.78 | 400,490,310.79 |
| 减:所得税费用 | 26,503,346.24 | 110,456,196.9 | 88,536,526.9 | 66,878,783.01 |
| 六、净利润 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 |
| 持续经营净利润 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 |
| 归属于母公司股东的净利润 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 |
| (一)基本每股收益 | 0.2 | 1.12 | 1.11 | 0.8 |
| (二)稀释每股收益 | 0.2 | 1.12 | 1.11 | 0.8 |
| 九、综合收益总额 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 |
| 归属于母公司股东的综合收益总额 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 |
| 公告日期 | 2024-04-30 | 2024-04-23 | 2023-10-27 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |